Smith & Nephew plc vs Warner Music Group Corp — how do they compare? Smith & Nephew plc trades at $27.1 (market cap $11.10B), while Warner Music Group Corp trades at $28.89 (market cap $15.12B). The key difference: Warner Music Group Corp is the larger of the two by market cap, and Smith & Nephew plc pays the higher dividend (2.95%). Which is the better fit depends on your goals — on Pluang, investors hold Smith & Nephew plc for 120 Days and Warner Music Group Corp for 96 Days on average.
| SNN | WMG | |
|---|---|---|
Market Cap | $11.10B | $15.12B |
Volume | 1,051,703 | 2,966,414 |
Sector | Health | Media |
52-Week High | $37.17 | $34.72 |
52-Week Low | $26.42 | $23.65 |
Typical Hold Time | 120 Days | 96 Days |
Enterprise Value | $14.13B | $19.42B |
Dividend Yield | 2.95% | 2.77% |
Signals from Pluang's Aura AI — not financial advice
SNN trades at $26.89, near its 52-week low, with a bearish technical signal. Revenue and net income have grown steadily, reaching $6.16B and $625M in 2025, respectively, with improving margins. Recent product launches, like the EVOS PELVIC System, aim to strengthen its medical technology portfolio. However, cash flow volatility and mixed analyst sentiment pose challenges.
The stock presents a value opportunity with reasonable valuation ratios (P/E 18.34, P/S 1.85), but risks include competitive pressures and recent CFO departure. Analyst consensus is cautious, with 65% hold ratings. Upside depends on execution of growth initiatives amid market headwinds.
Warner Music Group (WMG) trades at $28.16, up 1.99% today, with a bullish technical signal and strong analyst support. Recent earnings show revenue growth to $6.71B in 2025, though net income margin dipped to 5.44%. The company is actively engaging in AI partnerships and licensing renewals, positioning for future growth in the evolving media landscape.
The outlook for WMG is positive, driven by streaming growth and strategic AI initiatives, with a consensus price target of $39.50 implying significant upside. Risks include margin pressure and competitive dynamics in the music industry, but institutional buying and a 'Moderate Buy' consensus suggest confidence in its long-term value.
Trailing returns across standard periods
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 42% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 28% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.
Read more on SNN →Warner Music Group is the third largest of the three major global record labels, with Vivendi's Universal Music in first and Sony Music in second. Warner's larger segment, recorded music, consists of iconic labels like Atlantic Records, Warner Records, and Parlophone Records and popular artists such as Ed Sheeran, Cardi B, Dua Lipa, and Blake Shelton. Warner Chappell, the firm's publishing arm, is the home to over 65,000 composers and songwriters with over a million copyrights represented. Warner is controlled by Access Industries, which owns an 84% economic interest and 99% of voting rights.
Read more on WMG →